View in EDS

Plasmin-mediated fibrinolysis is required for hematopoietic recovery after 5-FU-induced myeloablation.

Saved in:
Bibliographic Details
Title: Plasmin-mediated fibrinolysis is required for hematopoietic recovery after 5-FU-induced myeloablation.
Authors: Nguyen TPL; Proteases and Tissue Remodeling Section, National Institute of Dental and Craniofacial research, National Institutes of Health, Bethesda, Maryland, United States., Jiang YG; Proteases and Tissue Remodeling Section, National Institute of Dental and Craniofacial research, National Institutes of Health, Bethesda, Maryland, United States., Ogan BM; Harvard University, Boston, Massachusetts, United States., Doyle AD; National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, Maryland, United States., Tran DT; NIH, Bethesda, Maryland, United States., Ward JM; Proteases and Tissue Remodeling Section, National Institute of Dental and Craniofacial research, National Institutes of Health, Bethesda, Maryland, United States., Zhang A; Proteases and Tissue Remodeling Section, National Institute of Dental and Craniofacial research, National Institutes of Health, Bethesda, Maryland, United States., Ferrer de Oliveira R; Harvard University, Boston, Massachusetts, United States., Ferraresso F; Versiti Blood Research Institute, Milwaukee, Wisconsin, United States., Bledsoe JR; Boston Children's Hospital, Boston, Massachusetts, United States., Kastrup CJ; Versiti Blood Research Institute, Milwaukee, Wisconsin, United States., Flick MJ; University of North Carolina, Chapel Hill, Chapel Hill, North Carolina, United States., Rowe RG; Boston Children's Hospital, Boston, Massachusetts, United States., Bugge TH; Retired, Bethesda, Maryland, United States., Silva LM; Harvard University, Boston, Massachusetts, United States.
Source: Blood advances [Blood Adv] 2026 Jun 18. Date of Electronic Publication: 2026 Jun 18.
Publication Type: Journal Article
Journal Info: Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 42314039
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Plasmin-mediated fibrinolysis is required for hematopoietic recovery after 5-FU-induced myeloablation.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Nguyen+TPL%22">Nguyen TPL</searchLink>; Proteases and Tissue Remodeling Section, National Institute of Dental and Craniofacial research, National Institutes of Health, Bethesda, Maryland, United States.<br /><searchLink fieldCode="AU" term="%22Jiang+YG%22">Jiang YG</searchLink>; Proteases and Tissue Remodeling Section, National Institute of Dental and Craniofacial research, National Institutes of Health, Bethesda, Maryland, United States.<br /><searchLink fieldCode="AU" term="%22Ogan+BM%22">Ogan BM</searchLink>; Harvard University, Boston, Massachusetts, United States.<br /><searchLink fieldCode="AU" term="%22Doyle+AD%22">Doyle AD</searchLink>; National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, Maryland, United States.<br /><searchLink fieldCode="AU" term="%22Tran+DT%22">Tran DT</searchLink>; NIH, Bethesda, Maryland, United States.<br /><searchLink fieldCode="AU" term="%22Ward+JM%22">Ward JM</searchLink>; Proteases and Tissue Remodeling Section, National Institute of Dental and Craniofacial research, National Institutes of Health, Bethesda, Maryland, United States.<br /><searchLink fieldCode="AU" term="%22Zhang+A%22">Zhang A</searchLink>; Proteases and Tissue Remodeling Section, National Institute of Dental and Craniofacial research, National Institutes of Health, Bethesda, Maryland, United States.<br /><searchLink fieldCode="AU" term="%22Ferrer+de+Oliveira+R%22">Ferrer de Oliveira R</searchLink>; Harvard University, Boston, Massachusetts, United States.<br /><searchLink fieldCode="AU" term="%22Ferraresso+F%22">Ferraresso F</searchLink>; Versiti Blood Research Institute, Milwaukee, Wisconsin, United States.<br /><searchLink fieldCode="AU" term="%22Bledsoe+JR%22">Bledsoe JR</searchLink>; Boston Children's Hospital, Boston, Massachusetts, United States.<br /><searchLink fieldCode="AU" term="%22Kastrup+CJ%22">Kastrup CJ</searchLink>; Versiti Blood Research Institute, Milwaukee, Wisconsin, United States.<br /><searchLink fieldCode="AU" term="%22Flick+MJ%22">Flick MJ</searchLink>; University of North Carolina, Chapel Hill, Chapel Hill, North Carolina, United States.<br /><searchLink fieldCode="AU" term="%22Rowe+RG%22">Rowe RG</searchLink>; Boston Children's Hospital, Boston, Massachusetts, United States.<br /><searchLink fieldCode="AU" term="%22Bugge+TH%22">Bugge TH</searchLink>; Retired, Bethesda, Maryland, United States.<br /><searchLink fieldCode="AU" term="%22Silva+LM%22">Silva LM</searchLink>; Harvard University, Boston, Massachusetts, United States.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101698425%22">Blood advances</searchLink> [Blood Adv] 2026 Jun 18. <i>Date of Electronic Publication: </i>2026 Jun 18.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Society+of+Hematology%22">American Society of Hematology </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101698425 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2473-9537 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2224739529%22">24739529 </searchLink><i>NLM ISO Abbreviation: </i>Blood Adv <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42314039
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1182/bloodadvances.2025019416
    Languages:
      – Code: eng
        Text: English
    Titles:
      – TitleFull: Plasmin-mediated fibrinolysis is required for hematopoietic recovery after 5-FU-induced myeloablation.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Nguyen TPL
      – PersonEntity:
          Name:
            NameFull: Jiang YG
      – PersonEntity:
          Name:
            NameFull: Ogan BM
      – PersonEntity:
          Name:
            NameFull: Doyle AD
      – PersonEntity:
          Name:
            NameFull: Tran DT
      – PersonEntity:
          Name:
            NameFull: Ward JM
      – PersonEntity:
          Name:
            NameFull: Zhang A
      – PersonEntity:
          Name:
            NameFull: Ferrer de Oliveira R
      – PersonEntity:
          Name:
            NameFull: Ferraresso F
      – PersonEntity:
          Name:
            NameFull: Bledsoe JR
      – PersonEntity:
          Name:
            NameFull: Kastrup CJ
      – PersonEntity:
          Name:
            NameFull: Flick MJ
      – PersonEntity:
          Name:
            NameFull: Rowe RG
      – PersonEntity:
          Name:
            NameFull: Bugge TH
      – PersonEntity:
          Name:
            NameFull: Silva LM
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 18
              M: 06
              Text: 2026 Jun 18
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 2473-9537
          Titles:
            – TitleFull: Blood advances
              Type: main
ResultId 1